Grifols Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Grifols Therapeutics

Access the complete profile.

Grifols Therapeutics Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Address	79 Tw Alexander Dr Research Triangle Park, NC 27709

Note: Revenues for privately held companies are statistical evaluations.


Grifols Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Grifols Therapeutics's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Grifols Therapeutics is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Trademark Applications

Trademark applications show the products and services that Grifols Therapeutics is developing and marketing. Grifols Therapeutics doesn't have any recent trademark applications, indicating Grifols Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
GAMUNEX CONNEXIONS [ Electronic publications, namely, downloadable newsletters featuring news and articles regarding patient health and wellness and patient care ]	01/26/2012
GAMUNEX-C Immune serum globulin	04/12/2010
PROLASTIN DIRECT Distributorship services in the field of biological and pharmaceutical products	04/21/2008

See all trademarks and details in the Full Report.

Market Share of Grifols Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Grifols Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Grifols Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
TERGUS PHARMA	Durham, NC	100
HUMACYTE GLOBAL	Durham, NC	87
MEDICAGO USA	Durham, NC	67
BRII BIOSCIENCES	Durham, NC	51
FENNEC PHARMACEUTICALS	Research Triangle Park, NC	46
DOVA PHARMACEUTICALS	Durham, NC	42

Future Competition: Grifols Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Grifols Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)